The evaluation of a biochemical or hematological quantity measured in a study group of employees during occupational health assessments involves a comparison with a reference sample group. Part of this evaluation consists of checking whether the percentage of values larger than a predetermined upper reference limit is significantly larger than the percentage normally expected (2.5%, if the 97.5 percentile is used as the upper reference limit). The reference limit, however, is estimated from a random reference sample, the size of which, for many reasons, may be relatively small; as a consequence, the reference limit estimate will be imprecise. Moreover, reference limits often need to be determined separately for each of a number of subgroups derived from personal characteristics such as age, gender, or body mass index. For these reasons, the number of reference values may be small; as a consequence, the reference limits estimates are highly imprecise (Fig. 1) .
The evaluation of a biochemical or hematological quantity measured in a study group of employees during occupational health assessments involves a comparison with a reference sample group. Part of this evaluation consists of checking whether the percentage of values larger than a predetermined upper reference limit is significantly larger than the percentage normally expected (2.5%, if the 97.5 percentile is used as the upper reference limit). The reference limit, however, is estimated from a random reference sample, the size of which, for many reasons, may be relatively small; as a consequence, the reference limit estimate will be imprecise. In situations in which the reference sample size is smaller than or not much larger than the study sample size, this imprecision results in the usual binomial test of significance being highly inappropriate. We provide an exact nonparametric test valid for all reference sample sizes.
Indexing Terms: reference values/binomial test/nonparametric test/statistics
In the petrochemical manufacturing and refinery complex of Shell Pernis in The Netherlands, voluntary occupational health assessments are offered to the employees everj 4 or 2 years. Evaluation of biochemical and hematological test results are part of such assessments.
Reference limits to be used in the evaluation of these health assessments are regularly updated for various reasons: Occupational health policies may have changed and person-and work-related risk factors may have increased or decreased, e.g., alcoholic beverages may no longer be served during lunchtime, the number of cigarette smokers may have decreased, and occupational exposure may be reduced because of improved working conditions.
Moreover, reference limits often need to be determined separately for each of a number of subgroups derived from personal characteristics such as age, gender, or body mass index. For these reasons, the number of reference values may be small; as a consequence, the reference limits estimates are highly imprecise (Fig. 1) .
Until recently, reference limits were used by our occupational health department only on an individual basis: They were used by the physician as a guideline for In statistical terms the problem is to test the no-effect hypothesis against the restricted alternative of a relatively long upper tail. We shall define the upper tail of the study population distribution to be relatively long if the probability of a study sample value being "extreme" is larger than expected if the no-effect hypothesis is true. This definition involves some choice of upper reference limit. We shall focus on the 97.5 percentile, since it is most frequently used on an individual level at our cccupational health department.
Of course, one may prefer a different percentile, or one may wish to test against several alternatives, each with a different upper reference limit. In the latter case one should bear in mind that the tests are strongly dependent.
This reference limit is to be estimated from the reference sample group. If the size of this sample, n, is large (say, >1000), then the conventional nonparametric estimate, described in the next section, is reasonably accurate, so that 2.5% is the approximate percentage of extreme values to be expected in case the no-effect hypothesis is true. (The degree of accuracy depends also on the percentile chosen: The closer to 100%, the less accurate this estimate can be.) Denoting the study sample size by m, the number of extreme values will then be approximately binomially distributed with success probabilityp = 0.025 and sample size m. The consequent test of significance, which we shall refer to as the binomial test, rejects the hypothesis if the number of extremes, S. is too large. The corresponding P-value is easily derived by summing all binomial distributions with sample size m and success probability p IIB(m,p)] probabilities of values larger or equal to the number of extreme values S. That is, the corresponding P-value equals (1) 0.025i0.975m_t
However, for reasons mentioned earlier, the reference sample size, n, can be small, with the consequence that the upper reference limit estimate will be highly imprecise. Hence, a comparison with p = 0.025 no longer makes sense. Figure 1 displays the density function of the actual upper-tail probabilities corresponding to the conventional 97.5 percentile estimate. (This distribution is the same for all underlying continuous reference distributions; see Appendix A.) Although 2.5% is nearly the most probable value, a value of, e.g., 4% is not unlikely, not even if n = 500. In the latter case the 97.5 percentile estimate actually coincides with the true 96 percentile. Here we provide an exact nonparametric solution to the testing problem that fully takes into account the random error involved in the estimation of the upper reference limit. It includes the conventional 97.5 percentile estimate, the reference sample size, and the study sample values. An actual case study is discussed in the last section.
Exact Nonparametric Test
We shall pretend to be ignorant of the precise shape of the reference distribution function. This is sensible, since premises regarding the shape of the distribution can have a large negative influence on the accuracy of the percentile estimate. To be more precise, the estimates obtained by postulating the reference distribution to belong to a parametric class of distribution (e.g., gaussian distributions), are nonrobust against departures from this postulate [see, e.g., (1), p 196]. In the context of hemat.ological or biochemical quantities, the only completely natural assumption we make is that the distribution functions considered are continuous.
The common, so-called nonparametric, estimate of the 97.5 percentile estimate is simply the jth largest value of the reference sample, wherej = n x 0.975 if it is an integer and the smallest integer larger than n X 0.975 otherwise. Thus, if n = 1000, thenj = 975, whereas if n = 100, then j = 98. [There is an extensive literature regarding nonparametric estimation of reference limits and related subjects; see, e.g., (1-4) .]
The natural test of significance is that which rejects the hypothesis if the number of values from the study sample larger than the estimated upper reference limit described above is too large. In case the hypothesis of no-effect holds, the exact probability that S equals s is given by (Appendix B.1)
The corresponding P-value is obtained by summing these probabilities over all s equal to or larger than the number of extreme values S (Appendix C). In Table 1 , critical values of both the exact and the binomial test Upper-tallprobabilitydifference (%) Having fixed the significance level a (= 1 -specificity) at the usual 5%, it is interesting to study the power (the sensitivity) of the exact test: How large is the probability of rejecting the no-effect hypothesis in case a particular deviation from this hypothesis is present? This question is particularly important in situations in which information is scarce, i.e., if n and rn are small. (For ii and m sufficiently large, even a small insignificant deviation from the no-effect hypothesis will be detected.)
To this end, we have modeled alternative situations representing shifts of the upper tail of various magnitudes. Power functions in the cases (a) iz = rn = 50; (b) n = 100, rn = 50; (c) n = 250, rn = 100; (d) n = 500, rn = 250; and (e) n = 1000, m = 500 are displayed in Fig.  2 . For example, if the actual upper-tail probability of the study sample distribution associated with the reference limit is 5.5% instead of 2.5%, large sample sizes are needed to detect this 3% difference with a 95% probability (see Fig. 2 , n = 1000, m = 500, power = 0.95). Differences >12% are detected with reasonably large probabifities even if sample sizes are moderately small (Fig. 2, n = 100, m = 50) . See Append ix B.2 for details.
Case Study
In the petrochemical manufacturing and refinery complex of Shell Pernis, reference limits for male employees of several biochemical and hematological tests have been redetermined in the 9-month period January-September 1992 ( Table 2 ). The reference sample sizes range from 73 for 1k1ine phosphatase of male employees <25 years of age to as many as 2091 for total protein of all male employees. Some reference limits are based on all periodic health assessments carried out in the above-mentioned period. The reference limits of the other tests are, because of a change of reagents at April 1,1992, based on all periodic health assessments carried out from April 1 to October 1, 1992 (Table 2) .
We shall regard these reference samples as independent random samples. There are some arguments that hold against the assumption of randomness. One might argue that employees are not randomly requested but that it is simply their turn according to the department's request scheme. This argument may easily be disproved by noting that the request scheme was initially more or less randomly composed. A possibly real nuisance may be caused by the fact that the periodic health assessments are voluntary. Albeit that the participation percentage is high (85-95%), it may be, however unlikely, that participation depends on the test at issue. We shall assume, without further notice, that this is not the case.
The reference limits displayed in Table 2 Table  2 show that differences occur especially in situations in which the study sample size m is not much smaller than the reference sample size n (see Table 1 (Depending on the workplace of the employee, a biochemical or hematological test either is or is not routinely performed, which explains why the study sample sizes can be different.) In practice, we intend to report results similar to those described above, not in aggregated form, but for each company separately and on a yearly basis instead of on a three-month basis. As these analyses will involve a number of relatively large companies (The Hague Central Office, NAM, Shell Laboratory Amsterdam), the sample sizes (rn) for these studies will be even larger than those of the illustrative analysis described above, making use of the exact test a necessity.
This 
Appendix B.1
Derivation of exact test. Let, as in Appendix A above, X1, ., X,, be the independent reference sample with underlying distribution function F, and let Y,, ..., Y be the independent random sample from the study population with underlying distribution function G. We assume F and G to be continuous. The hypothesis to be tested is that of no-effect H0: F = G, against the restricted alternative H,: 
